Two-thirds of toddlers with peanut allergy who used the VIASKIN Peanut patch from DBV Technologies completed an oral food ...
GlobalData on MSN15d
Palforzia’s peanut allergy treatment use in Europe expanded to toddlersThe extension to the marketing authorisation means paediatric patients aged up to 17 years with a confirmed diagnosis of peanut allergy can use the immunotherapy. It can also be u ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback